Published in Cancer Weekly, October 10th, 2000
The protein, which is characterized as being a member of the transforming growth factor (TGF) beta 1 receptor structure, is called endoglin. According to researchers reporting in the journal Obstetrics and Gynecology, endoglin might be an endothelial marker for new growth in cervical cancers.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.